Robert Bowser
9Patents
2h-index
5Co-inventors
40Inventor score
Filing activity: Oct 25, 2004 → Jan 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7572596B2 | Modulation of the neuroendoctrine system as a therapy for motor neuron disease | Emerging Cross-Sectional Technologies | 25 | Expired |
| US8338572B2 | Kits for biomarker detection and treatment selection | Physics | 2 | Active |
| US8465727B2 | Biomarkers for the diagnosis of ALS | Physics | 2 | Active |
| US9983217B2 | Nuclear stress response in motor neuron disease and other neurological diseases | Physics | 1 | Active |
| US8841079B2 | Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain | Physics | 1 | Active |
| US8202510B2 | Biomarkers for amyotrophic lateral sclerosis | Emerging Cross-Sectional Technologies | 0 | Active |
| US7858071B2 | Biomarkers for amyotrophic lateral sclerosis | Emerging Cross-Sectional Technologies | 0 | Active |
| US10359436B2 | Nuclear stress response in motor neuron disease and other neurological diseases | Physics | 0 | Active |
| US12050217B2 | Chitinase proteins in neurologic disease | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.